Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.

Kuritzkes DR, Ribaudo HJ, Squires KE, Koletar SL, Santana J, Riddler SA, Reichman R, Shikuma C, Meyer WA, Klingman KL, Gulick RM. Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s. J Infect Dis. 2007 Apr 15; 195(8):1169-76.

View in: PubMed

subject areas

Alkynes
Anti-HIV Agents
Benzoxazines
Cyclopropanes
Dideoxynucleosides
Drug Therapy, Combination
Female
HIV Infections
HIV-1
Humans
Lamivudine
Male
Prospective Studies
Regression Analysis
RNA, Viral
Time Factors
Zidovudine

authors with profiles

Cecilia M. Shikuma,MD
Jorge Santana

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support